Clinical Trial Update: A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

This document notes a Phase II clinical trial evaluating spatially fractionated radiotherapy combined with the PraG strategy for soft tissue sarcoma, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Soft Tissue Sarcoma (STS) | Phase 2 | Status: NOT_YET_RECRUITING